CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.
Saved in:
| Title: | CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses. |
|---|---|
| Authors: | Jalloh S; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America., Olejnik J; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, United States of America., Berrigan J; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America., Nisa A; Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America., Suder EL; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, United States of America., Akiyama H; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America., Lei M; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America., Ramaswamy S; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America., Tyagi S; Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America., Bushkin Y; Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America., Mühlberger E; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, United States of America., Gummuluru S; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2022 Oct 24; Vol. 18 (10), pp. e1010479. Date of Electronic Publication: 2022 Oct 24 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36279285 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jalloh+S%22">Jalloh S</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Olejnik+J%22">Olejnik J</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Berrigan+J%22">Berrigan J</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Nisa+A%22">Nisa A</searchLink>; Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America.<br /><searchLink fieldCode="AU" term="%22Suder+EL%22">Suder EL</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Akiyama+H%22">Akiyama H</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Lei+M%22">Lei M</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Ramaswamy+S%22">Ramaswamy S</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Tyagi+S%22">Tyagi S</searchLink>; Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America.<br /><searchLink fieldCode="AU" term="%22Bushkin+Y%22">Bushkin Y</searchLink>; Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America.<br /><searchLink fieldCode="AU" term="%22Mühlberger+E%22">Mühlberger E</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Gummuluru+S%22">Gummuluru S</searchLink>; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2022 Oct 24; Vol. 18 (10), pp. e1010479. <i>Date of Electronic Publication: </i>2022 Oct 24 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36279285 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.ppat.1010479 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1010479 Titles: – TitleFull: CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jalloh S – PersonEntity: Name: NameFull: Olejnik J – PersonEntity: Name: NameFull: Berrigan J – PersonEntity: Name: NameFull: Nisa A – PersonEntity: Name: NameFull: Suder EL – PersonEntity: Name: NameFull: Akiyama H – PersonEntity: Name: NameFull: Lei M – PersonEntity: Name: NameFull: Ramaswamy S – PersonEntity: Name: NameFull: Tyagi S – PersonEntity: Name: NameFull: Bushkin Y – PersonEntity: Name: NameFull: Mühlberger E – PersonEntity: Name: NameFull: Gummuluru S IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 10 Text: 2022 Oct 24 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1553-7374 Numbering: – Type: volume Value: 18 – Type: issue Value: 10 Titles: – TitleFull: PLoS pathogens Type: main |
| ResultId | 1 |